A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

According to reports circulating last week, the Government is set to kick into the long grass the proposal for a national ...

UroLift is a minimally invasive treatment for Benign Prostatic Hyperplasia, a condition that causes an enlarged prostate in ...

One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society.

If you’re tired of sleepless nights and discomfort, this ProstaVive reviews reveals how one scoop a day make a big difference ...

Protecting your prostate health involves proactive lifestyle choices. Experts recommend a plant-based, high-fibre diet rich ...

In a ground-breaking medical achievement, Nigeria has become the first country in West and Central Africa to successfully ...

Preclinical study showed PDIA1 and PDIA5 protect cells from oxidative stress, maintain mitochondrial function, and are involved in androgen receptor regulation.

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

New research indicates that high levels of folate and vitamin B12 may elevate prostate cancer risk, particularly for ...

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...

To improve the quality of life of people with cancer, oncologists have regularly recommended exercise. “The thinking in the ...